SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-21-016875
Filing Date
2021-03-31
Accepted
2021-03-31 08:00:53
Documents
84
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K apvo-10k_20201231.htm 10-K 2353495
2 EX-4.5 apvo-ex45_509.htm EX-4.5 33318
3 EX-21.1 apvo-ex211_10.htm EX-21.1 6017
4 EX-23.1 apvo-ex231_9.htm EX-23.1 10291
5 EX-23.2 apvo-ex232_11.htm EX-23.2 9699
6 EX-31.1 apvo-ex311_7.htm EX-31.1 20683
7 EX-31.2 apvo-ex312_8.htm EX-31.2 21381
8 EX-32.1 apvo-ex321_12.htm EX-32.1 10354
9 EX-32.2 apvo-ex322_6.htm EX-32.2 10422
10 GRAPHIC gcbqmfnojuj2000001.jpg GRAPHIC 317482
11 GRAPHIC gcbqmfnojuj2000003.jpg GRAPHIC 146178
12 GRAPHIC gcbqmfnojuj2000002.jpg GRAPHIC 75999
  Complete submission text file 0001564590-21-016875.txt   8790076

Data Files

Seq Description Document Type Size
13 XBRL INSTANCE DOCUMENT apvo-20201231.xml EX-101.INS 1376400
14 XBRL TAXONOMY EXTENSION SCHEMA apvo-20201231.xsd EX-101.SCH 73141
15 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE apvo-20201231_cal.xml EX-101.CAL 69395
16 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE apvo-20201231_def.xml EX-101.DEF 232181
17 XBRL TAXONOMY EXTENSION LABEL LINKBASE apvo-20201231_lab.xml EX-101.LAB 535304
18 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apvo-20201231_pre.xml EX-101.PRE 414162
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37746 | Film No.: 21789878
SIC: 2834 Pharmaceutical Preparations